Canadian Council of the Blind

Toll-Free: 1 877-304-0968

May 2024 Vision Health Month Conference

Canadian Council of the Blind (80 Years' Logo) - Le Conseil Canadien des Aeugles (Logo des 80 ans)

The Canadian Council of the Blind Presents
Its May 2024 Vision Health Month Conference
The Role of Artificial Intelligence (AI) in Vision Health

Attend Live or Virtually
Tuesday, May 21, 2024
10:00 am – 1:00 pm (EDT)
Eastern Daylight Time.

The Great Hall, Christ Church Cathedral
414 Sparks Street, Ottawa, ON K1R 0B2

A continental breakfast will be served from 9:15 am – 10:00 am (EDT).

On behalf of the Canadian Council of the Blind, we invite you to attend a special discussion on artificial intelligence (AI). AI is very much in the news these days as new algorithms and uses for it emerge almost on a daily basis. This conference will provide a wide view of the potential uses of AI in the field of vision health, focusing on technologies that are the most advanced and most likely to be implemented in the short term.

  1. Background – Dr. Jutta Treviranus
    Dr. Treviranus will provide an overview of the different forms of AI, the risks and opportunities posed by the design of AI, emerging regulations relevant to people with disabilities, and promising trends in AI.
  2. Application of AI in Ophthalmology – Dr. Delan Jinapriya
    Dr. Jinapriya will describe the potential use of AI in the diagnosis of eye diseases based on his personal experience and research over the past several years. In particular, he will discuss the use of AI in:
    a. The Diagnosis of Glaucoma: Early diagnosis is the key to early treatment and prevention of vision loss due to glaucoma. This presentation will present a number of applications in which AI is being used to diagnose glaucoma and what we might expect in the future.
    b. The Diagnosis of Diabetic Retinopathy: This presentation will describe a Health Canada-approved AI program for the early detection of diabetic retinopathy as well as other research currently directed to the early detection of retinal diseases.
    c. The Diagnosis of Macular Degeneration: This presentation will describe a Health Canada-approved AI program for the detection of macular degeneration.
  3. Application of AI in Increasing the Accessibility of Devices for People Living with Blindness or Sight Loss – Jason Fayre
    This presentation will describe how AI is already being used in the creation of accessible devices such as smart glasses. It will describe areas of current accessible device research using AI and what we might expect in the future.

Attend Live or Virtually


If you require assistance registering,
please contact us at [email protected]
or by phone at 1.877.304.0968.

Presenting Sponsors: Abbvie, AMI, Apellis, Astellas, Bausch and Lomb, Bayer, Biogen, Janssen Johnson & Johnson, MacuMira, Roche, Specsavers, Via Rail Canada
Scroll to Top
Skip to content